Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

BioHarvest Sciences Inc. - Common Stock (NQ:BHST)

1.680 -0.090 (-5.08%)
Streaming Delayed Price Updated: 11:57 AM EDT, Sep 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,149
Open 1.730
Bid (Size) 1.680 (100)
Ask (Size) 1.700 (3,700)
Prev. Close 1.770
Today's Range 1.660 - 1.742
52wk Range 1.620 - 12.80
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
BioHarvest Advances Botanical Synthesis Leadership as VINIA Daily Chews Unlock More Value from Its First Consumer Product
Single-dose VINIA Daily Chews broaden demographics and usage occasions while demonstrating the commercial versatility of Botanical SynthesisFormat expansion shows how... 
Via Newsfile
News headline image
BioHarvest Sciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 14, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0),... 
Via Newsfile

Performance

YTD
-67.8%
-67.8%
1 Month
-22.6%
-22.6%
3 Month
-49.2%
-49.2%
6 Month
-61.5%
-61.5%
1 Year
-81.5%
-81.5%

More News

Read More
News headline image
BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)
Via Newsfile
News headline image
Q3 Virtual Investor Summit Presentations Now Available On Demand
From Investor Summit Group
Via ACCESS Newswire
News headline image
Investor Summit | MicroCap Opportunities to Watch - August 26
From Investor Summit Group
Via ACCESS Newswire
News headline image
BioHarvest Sciences (BHST) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
BioHarvest Sciences Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update
Via Newsfile
News headline image
BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance
Via Newsfile
News headline image
BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference
Via Newsfile
News headline image
BioHarvest Sciences to Report Second Quarter 2026 Financial Results on August 11, 2026
Via Newsfile
Topics Earnings
News headline image
BioHarvest Awarded $1.4M Grant from the Israel Innovation Authority to Pioneer AI-Driven Plant-Cell Synthesis
Via Newsfile
Topics Artificial Intelligence
News headline image
BioHarvest Sciences to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC
Via Newsfile
Topics Derivatives
News headline image
Q2 Investor Summit Virtual Live Wednesday June 24
From Investor Summit Group
Via ACCESS Newswire
News headline image
BioHarvest Sciences to Present at the 2026 BIO International Convention
Via Newsfile
News headline image
BioHarvest (BHST) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
BioHarvest (BHST) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation
Via Newsfile
News headline image
BioHarvest Sciences Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
BioHarvest Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
Via Newsfile
News headline image
BioHarvest Sciences Appoints New Head of Business Development for its CDMO Division
Via Newsfile
News headline image
BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications
Via Newsfile
Topics Economy
News headline image
BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform
Via Newsfile
News headline image
BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026
Via Newsfile
Topics Earnings
News headline image
BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy
Via Newsfile

Frequently Asked Questions

Is BioHarvest Sciences Inc. - Common Stock publicly traded?
Yes, BioHarvest Sciences Inc. - Common Stock is publicly traded.
What exchange does BioHarvest Sciences Inc. - Common Stock trade on?
BioHarvest Sciences Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioHarvest Sciences Inc. - Common Stock?
The ticker symbol for BioHarvest Sciences Inc. - Common Stock is BHST on the Nasdaq Stock Market
What is the current price of BioHarvest Sciences Inc. - Common Stock?
The current price of BioHarvest Sciences Inc. - Common Stock is 1.680
When was BioHarvest Sciences Inc. - Common Stock last traded?
The last trade of BioHarvest Sciences Inc. - Common Stock was at 09/16/26 11:57 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.